BioDiscovery and Empire Genomics to Integrate, Co-Market aCGH Tech and Related Software | GenomeWeb
NEW YORK (GenomeWeb News) — Empire Genomics and BioDiscovery will integrate and co-market certain of their products for the array comparative genomic hybridization market, BioDiscovery said Wednesday. 
 
Empire Genomics, a Buffalo, NY-based start-up, specializes in molecular karyotyping technology in an aCGH platform that is used to quantify “changes in chromosomal abnormalities,” BioDisovery said.
 
BioDiscovery will provide image and aCGH software to the partnership.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.